BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 17675253)

  • 21. Molecular studies of visna virus gene expression: analysis of envelope gene expression in transgenic sheep.
    Clements JE; Hu L; Lindstrom L; Powell A; Rexroad C; Zink MC
    AIDS Res Hum Retroviruses; 1996 Mar; 12(5):421-3. PubMed ID: 8882324
    [No Abstract]   [Full Text] [Related]  

  • 22. Expression of bovine leukaemia virus antigens fused to MS2 polymerase in E. coli.
    Ulrich R; Bähring S; Siakkou H; Rosenthal S
    Acta Virol; 1991 Aug; 35(4):391-5. PubMed ID: 1686964
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mapping and characterization of visna/maedi virus cytotoxic T-lymphocyte epitopes.
    Wu C; Barbezange C; McConnell I; Blacklaws BA
    J Gen Virol; 2008 Oct; 89(Pt 10):2586-2596. PubMed ID: 18796728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mucosal vaccination with an attenuated maedi-visna virus clone.
    Pétursson G; Matthíasdóttir S; Svansson V; Andrésdóttir V; Georgsson G; Martin AH; Agnarsdóttir G; Gísladóttir E; Arnadóttir S; Högnadóttir S; Jónsson SR; Andrésson OS; Torsteinsdóttir S
    Vaccine; 2005 May; 23(24):3223-8. PubMed ID: 15837223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sequence variation in the gp135 gene of Maedi visna virus strain EV1.
    Carey N; Dalziel RG
    Virus Genes; 1994 Mar; 8(2):115-23. PubMed ID: 8073632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Marker gene swapping facilitates recombinant Modified Vaccinia Virus Ankara production by host-range selection.
    Di Lullo G; Soprana E; Panigada M; Palini A; Erfle V; Staib C; Sutter G; Siccardi AG
    J Virol Methods; 2009 Mar; 156(1-2):37-43. PubMed ID: 19038289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA Vaccines Against Maedi-Visna Virus.
    Henriques AM; Fevereiro M; Monteiro GA
    Methods Mol Biol; 2016; 1404():59-76. PubMed ID: 27076290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Precursor polypeptides to structural proteins of visna virus.
    Vigne R; Filippi P; Quérat G; Sauze N; Vitu C; Russo P; Delori P
    J Virol; 1982 Jun; 42(3):1046-56. PubMed ID: 6178845
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Construction and characterization of an infectious molecular clone of maedi-visna virus that expresses green fluorescent protein.
    Gudmundsdóttir HS; Olafsdóttir K; Franzdóttir SR; Andrésdóttir V
    J Virol Methods; 2010 Sep; 168(1-2):98-102. PubMed ID: 20447418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Construction, expression and immunoassay detection of recombinant plasmid encoding fusion protein of Roman chicken complement C3d and Newcastle disease virus F gene.
    Liu D; Niu ZX
    Scand J Immunol; 2008 Dec; 68(6):598-606. PubMed ID: 19055698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of herpes simplex virus 1 glycoprotein D in prokaryotic and eukaryotic cells.
    Mosko T; Kosovský J; Rezuchová I; Durmanová V; Kúdelová M; Rajcáni J
    Acta Virol; 2004; 48(2):97-107. PubMed ID: 15462285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effective method of introducing plasmid DNA into eukaryotic cells by using liposomes for producing vaccinia virus recombinants].
    Slepushkin VA; Bukrinskiĭ MI
    Biull Eksp Biol Med; 1987 Oct; 104(10):478-80. PubMed ID: 2823928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro translation of fractionated virus-specific RNA isolated from plasma of chicken infected by avian myeloblastosis virus. Unprocessed and processed myeloblastosis-associated virus env-polypeptide precursors.
    Malý A
    Acta Virol; 1993 Dec; 37(6):493-501. PubMed ID: 7516622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic characterization of maedi-visna virus (MVV) detected in Finland.
    Laamanen I; Jakava-Viljanen M; Sihvonen L
    Vet Microbiol; 2007 Jun; 122(3-4):357-65. PubMed ID: 17349752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modification of a viral envelope glycoprotein cell-cell fusion assay by utilizing plasmid encoded bacteriophage RNA polymerase.
    Lin G; Murphy SL; Gaulton GN; Hoxie JA
    J Virol Methods; 2005 Sep; 128(1-2):135-42. PubMed ID: 15941597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sequence variation in the envelope gene and the LTR of maedi-visna virus.
    Andrésdóttir V; Tang X; Andrésson OS; Georgsson G
    Ann N Y Acad Sci; 1994 Jun; 724():157-8. PubMed ID: 8030935
    [No Abstract]   [Full Text] [Related]  

  • 37. Detection of maedi-visna virus in the kidneys of naturally infected sheep.
    Angelopoulou K; Brellou GD; Vlemmas I
    J Comp Pathol; 2006 May; 134(4):329-35. PubMed ID: 16709422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experimental Maedi Visna Virus Infection in sheep: a morphological, immunohistochemical and PCR study after three years of infection.
    Preziuso S; Taccini E; Rossi G; Renzoni G; Braca G
    Eur J Histochem; 2003; 47(4):373-8. PubMed ID: 14706934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mammalian cell/vaccinia virus expression vectors with increased stability of retroviral sequences in Escherichia coli: production of feline immunodeficiency virus envelope protein.
    Wang RF; Mullins JI
    Gene; 1995 Feb; 153(2):197-202. PubMed ID: 7875588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of maedi-visna virus major core protein, p25: development of a sensitive p25 antigen detection assay.
    Reyburn HT; Roy DJ; Blacklaws BA; Sargan DR; McConnell I
    J Virol Methods; 1992 Jun; 37(3):305-20. PubMed ID: 1321836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.